These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22391789)
1. Issues and challenges of subvisible and submicron particulate analysis in protein solutions. Scherer TM; Leung S; Owyang L; Shire SJ AAPS J; 2012 Jun; 14(2):236-43. PubMed ID: 22391789 [TBL] [Abstract][Full Text] [Related]
2. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress. Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805 [TBL] [Abstract][Full Text] [Related]
3. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products. Zhang L; Shi S; Antochshuk V J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725 [TBL] [Abstract][Full Text] [Related]
4. Protein particulate detection issues in biotherapeutics development--current status. Das TK AAPS PharmSciTech; 2012 Jun; 13(2):732-46. PubMed ID: 22566174 [TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods. Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051 [TBL] [Abstract][Full Text] [Related]
9. Contribution of Intravenous Administration Components to Subvisible and Submicron Particles Present in Administered Drug Product. Pollo M; Mehta A; Torres K; Thorne D; Zimmermann D; Kolhe P J Pharm Sci; 2019 Jul; 108(7):2406-2414. PubMed ID: 30849460 [TBL] [Abstract][Full Text] [Related]
10. A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein Products. Hubert M; Yang DT; Kwok SC; Rios A; Das TK; Patel A; Wuchner K; Antochshuk V; Junge F; Bou-Assaf GM; Cao S; Saggu M; Montrond L; Afonina N; Kolhe P; Loladze V; Narhi L J Pharm Sci; 2020 Jan; 109(1):830-844. PubMed ID: 31647951 [TBL] [Abstract][Full Text] [Related]
11. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. Singh SK; Afonina N; Awwad M; Bechtold-Peters K; Blue JT; Chou D; Cromwell M; Krause HJ; Mahler HC; Meyer BK; Narhi L; Nesta DP; Spitznagel T J Pharm Sci; 2010 Aug; 99(8):3302-21. PubMed ID: 20310025 [TBL] [Abstract][Full Text] [Related]
13. Micro-Flow Imaging: Estimation of the Contribution of Key Factors to the Variability of Subvisible Particle Count Measurement by a Nested Statistical Analysis. Zhang K; Wrzosek T; Desai KG; Monck M PDA J Pharm Sci Technol; 2020; 74(1):15-26. PubMed ID: 31519785 [TBL] [Abstract][Full Text] [Related]
14. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods. Werk T; Volkin DB; Mahler HC Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624 [TBL] [Abstract][Full Text] [Related]
15. Quantitation of protein particles in parenteral solutions using micro-flow imaging. Huang CT; Sharma D; Oma P; Krishnamurthy R J Pharm Sci; 2009 Sep; 98(9):3058-71. PubMed ID: 18937372 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Particle Techniques for the Characterization of Subvisible Particles From Elastomeric Closure Components. Rech J; Fradkin A; Krueger A; Kraft C; Paskiet D J Pharm Sci; 2020 May; 109(5):1725-1735. PubMed ID: 32017902 [TBL] [Abstract][Full Text] [Related]
17. Silicone Migration From Baked-on Silicone Layers. Particle Characterization in Placebo and Protein Solutions. Funke S; Matilainen J; Nalenz H; Bechtold-Peters K; Mahler HC; Friess W J Pharm Sci; 2016 Dec; 105(12):3520-3531. PubMed ID: 27773525 [TBL] [Abstract][Full Text] [Related]
18. Unmasking translucent protein particles by improved micro-flow imaging™ algorithms. Pedersen JS; Persson M J Pharm Sci; 2014 Jan; 103(1):107-14. PubMed ID: 24281987 [TBL] [Abstract][Full Text] [Related]
19. Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection. Allen LV Int J Pharm Compd; 2022; 26(3):219-228. PubMed ID: 35657746 [TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles. Tian X; Nejadnik MR; Baunsgaard D; Henriksen A; Rischel C; Jiskoot W J Pharm Sci; 2016 Nov; 105(11):3366-3375. PubMed ID: 27663383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]